ARRHYTHMIAS-AF RHYTHM CONTROL

From NeuroRehab.wiki

Revision as of 20:17, 13 March 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY

1. No or minimal heart disease: flecainide, propafenone, sotalol, and dronedarone; if ineffective, then amiodarone, dofetilide, or catheter ablation.

2. Heart failure (EF < 35%): amiodarone or dofetilide (not dronedarone); if ineffective, then catheter ablation.

3. CAD: dofetilide or sotalol; if ineffective, then amiodarone or catheter ablation.

4. HTN: LVH present - use amiodarone; if ineffective, then catheter ablation. LVH not present: use flecainide, propafenone, or sotalol. If these fail, then go to amiodarone, dofetilide, or catheter ablation.


Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].